Hexahydrocannabinol is a psychoactive substance that has a similar effect in humans as the cannabis compound THC. Because HHC is made using phytocannabinoids like CBD it is classed as a semi-synthetic cannabinoid (SSC) and was the first SSC to be officially recognised in Europe in 2022. HCC was synthesised for the first time in 1947 using THC, however in the modern day CBD is typically preferred. Clinical investigation into the effects HHC can have on the body are relatively recent and so, research is limited.&nbsp;
To find out more about HHC click <a href="https://www.emcdda.europa.eu/news/2023/new-cannabinoid-hhc-spotlight-market-evolves_en#:~:text=A%20closely%20monitored%20substance%20by,be%20reported%20in%20the%20EU.">here</a>

HHC: Hexahydrocannabinol

HHC, or Hexahydrocannabinol, is a derivative of THC that can be manufactured synthetically in laboratories using cannabis compounds.
